Healthcare Huddle
Topics
Weight Management

Weight Management

Huddle Trends Medicine Inefficiency Insights Artificial Intellgience Public Health Residency Reflections Policy Drug Supply Chain Weight Management Sponsored Deep Dives Concepts Transitions of Care Insurance Digital Health Business

The Future of Obesity Care: GLP-1s, Compounding & Surgery Trends

Huddle #Trends

Jared Dashevsky, MD

Jared Dashevsky, MD

Are Continuous Glucose Monitors Worth It for Those Without Diabetes?

Jared Dashevsky, MD

Jared Dashevsky, MD

23andMe’s New GLP-1 Service: Exploring Compounded Medications

Jared Dashevsky, MD

Jared Dashevsky, MD

Dexcom and Abbott’s FDA-Cleared CGMs: A Consumer Market Revolution

Jared Dashevsky, MD

Jared Dashevsky, MD

Navigating Obesity Care in the Digital Age

Huddle+ | Huddle #Trends

Jared Dashevsky, MD

Jared Dashevsky, MD

Semaglutide: A Medical Marvel or an Economic Enigma?

Jared Dashevsky, MD

Jared Dashevsky, MD

I Was Right (and Wrong) About the Weight Management Space

Jared Dashevsky, MD

Jared Dashevsky, MD

Do Weight-management Startups Have a Future?

Jared Dashevsky, MD

Jared Dashevsky, MD

The Future of Obesity Care

Jared Dashevsky, MD

Jared Dashevsky, MD

Eli Lilly’s To-Be Blockbuster Anti-Obesity Drug Receives Fast-Track Designation

Jared Dashevsky, MD

Jared Dashevsky, MD

The Next Frontier of Weight Loss

Jared Dashevsky, MD

Jared Dashevsky, MD